|
St. Jude Gets Expected Form 483, Warning Letter Still a Possibility
St. Jude filed an Oct. 24 Form 8-K with the SEC stating the company had received a Form 483 for observations made during a Sept. 25 to Oct. 17 FDA inspection of its Sylmar, Calif., cardiac rhythm management (CRM) plant.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives